- Home
- THR vs ORKA Comparison
THR vs ORKA Comparison
Compare THR & ORKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | THR | ORKA |
|---|---|---|
| Founded | 1954 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2011 | N/A |
Fundamental Metrics
Financial Performance| Metric | THR | ORKA |
|---|---|---|
| Price | $64.09 | $58.26 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 12 |
| Target Price | $54.00 | ★ $92.50 |
| AVG Volume (30 Days) | 635.3K | ★ 2.0M |
| Earning Date | 05-21-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.97 | N/A |
| EPS | ★ 1.27 | N/A |
| Revenue | ★ $276,181,000.00 | N/A |
| Revenue This Year | $6.08 | N/A |
| Revenue Next Year | $5.95 | N/A |
| P/E Ratio | $51.37 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.86 | $10.16 |
| 52 Week High | $71.24 | $91.00 |
Technical Indicators
Market Signals| Indicator | THR | ORKA |
|---|---|---|
| Relative Strength Index (RSI) | 57.94 | 42.42 |
| Support Level | $24.85 | $26.02 |
| Resistance Level | $71.24 | $91.00 |
| Average True Range (ATR) | 2.84 | 4.36 |
| MACD | -0.13 | -1.77 |
| Stochastic Oscillator | 44.17 | 4.25 |
Price Performance
Historical ComparisonAbout THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered industrial process heating solutions for process industries. It offers a full suite of products (heating units, electrode and gas-fired boilers, heating cables, industrial heating blankets and related products, temporary power solutions and tubing bundles), services (engineering, installation and maintenance services) and software (design optimization and wireless and network control systems) required to deliver comprehensive solutions to some of the world's Large and most complex projects. Its products and services include a wide range of electric heat tracing cables, steam heating solutions, controls, monitoring and software, instrumentation, project services, industrial heating and filtration solutions.
About ORKA Oruka Therapeutics Inc.
Oruka Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. The company's co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. These programs each bind their respective targets at high affinity and incorporate half-life extension technology to increase exposure and decreasing dosing frequency.